Use this section to discuss your experiences with prescription drugs, iron injections, and other medical interventions that involve the introduction of a drug or medicine into the body. Discuss side effects, successes, failures, published research, information about drug trials, and information about new medications being developed.
Important: Posts and information in this section are based on personal experiences and recommendations; they should not be considered a substitute for the advice of a healthcare provider.
NeurologyLive reached out to GlaxoSmithKline for comment, and a spokesperson said that "this was a business decision based on low and declining patient demand due to [the] availability of numerous generic ropinirole alternatives. Patients should speak to their physician about an appropriate alternative if they are taking Requip IR or XL. This decision was made independently of any [GlaxoSmithKline] development programs."
It would appear that generic ropinirole will remain available.
PB, I looked at the FDA list of approved generic vendors as well as companies that have applied to manufacture ropinirole. There are currently two companies in India that are approved to supply it and several others whose applications are waiting. It therefore appears that GSK is simply planning to leave the generic Requip market to the others and concentrate on the ER version, which is still under patent protection.
Steve
https://www.mayoclinicproceedings.org/a ... 0/fulltext
Opinions presented by Discussion Board Moderators are personal in nature and do not, in any way, represent the opinion of the RLS Foundation, and are not medical advice.